Compare CSTM & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSTM | AMRX |
|---|---|---|
| Founded | 2010 | 2002 |
| Country | France | United States |
| Employees | 11500 | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 5.8B |
| IPO Year | 2012 | 2018 |
| Metric | CSTM | AMRX |
|---|---|---|
| Price | $27.33 | $17.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $30.75 | $15.60 |
| AVG Volume (30 Days) | 1.6M | ★ 2.1M |
| Earning Date | 04-29-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 405.26 | 157.89 |
| EPS | ★ 1.42 | 0.19 |
| Revenue | ★ $8,449,000,000.00 | N/A |
| Revenue This Year | $21.46 | $4.48 |
| Revenue Next Year | $0.50 | $7.13 |
| P/E Ratio | ★ $19.84 | $94.26 |
| Revenue Growth | ★ 15.19 | N/A |
| 52 Week Low | $13.04 | $7.67 |
| 52 Week High | $36.99 | $18.39 |
| Indicator | CSTM | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 30.64 | 66.24 |
| Support Level | $22.10 | $16.45 |
| Resistance Level | $31.20 | $17.86 |
| Average True Range (ATR) | 1.10 | 0.55 |
| MACD | -0.23 | -0.06 |
| Stochastic Oscillator | 4.07 | 63.14 |
Constellium SE is engaged in the development, manufacture and sale of a broad range of high value-added specialty rolled and extruded aluminum products to the aerospace, space, defense, packaging, automotive, commercial transportation and general industrial end-markets. Its business model is to add value by converting aluminum into semi-fabricated and, in some instances, fully-fabricated alloyed aluminum products that meet stringent and performance-critical requirements from customers. It operates through three segments: Aerospace & Transportation Operating Segment, Packaging & Automotive Rolled Products Operating Segment, and Automotive Structures & Industry Operating Segment. It serves Aerospace, Packaging and Automotive and operates in the United States, France, Germany and others.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.